13F-HR filed by Euclidean Capital LLC
Euclidean Capital LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 15 holding rows worth $427,827,000.
- Accession
- 0001012975-21-000313
- Filer
- CIK 1825034
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 15 entries on the cover page, a total value of $427,827,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $427,827,000 with VALUE read as thousands by filing date, 13F file number 028-20777. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,908,677 | $133,520,000 | thousands by filing date | |
| 23ANDME HOLDING CO | 90138Q108 | CLASS A COM | 10,243,119 | $119,742,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 1,493,349 | $29,449,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 323,749 | $25,395,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 735,801 | $23,391,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 980,894 | $20,432,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 554,325 | $18,736,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 996,734 | $17,632,000 | thousands by filing date | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 1,261,261 | $13,458,000 | thousands by filing date | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 47,136 | $11,397,000 | thousands by filing date | |
| 1ST FINL BANCORP | 320209109 | COM | 173,576 | $4,102,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 154,426 | $4,097,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 31,131 | $4,007,000 | thousands by filing date | |
| PDD HOLDINGS INC SPONSORED ADS | 722304102 | ADR | 9,806 | $1,246,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 25,866 | $1,223,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-21-000313 | this filing | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-21-000457 | base | 2021-11-15 | acceptance time not in the bulk data set |